|Day Low/High||73.85 / 77.40|
|52 Wk Low/High||27.43 / 94.28|
The response to GeForce has been overwhelmingly positive.
As we hear all this chatter about the year 2000, I'll show you a trade in a big name from that year.
Sarge chooses Disneyland over Vegas and answers your questions, including who's next to a $2 trillion market cap after Apple.
Don't confuse what's happening on the S&P with the nation's economy.
Plus, the equity markets suddenly are trading quite listlessly and Applied Materials surprises.
The memory giant indicated November quarter sales would be below its preliminary outlook, and also says its August quarter will be more back-end loaded than originally expected.
A small trading position or bull call spread might be warranted, depending on support.
Perhaps not as a long-term investment, but the giant chipmaker could make for a good short-term trade.
Plus, it may be early to call it a worry, but keep a good eye out for inflation.
Not much is expected when CSCO reports fiscal Q4 earnings. Here's how I'm playing it.
While many tech companies topped their Q2 sales and earnings estimates, some made it clear that they're not out of the woods yet.
It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.
While valuations are clearly very high for many tech names, investor euphoria might not go away until news flow meaningfully worsens.
Blame the Fed? No. I'm reserving my wrath for the clueless buyers who appear to have taken a permanent intellectual summer vacation.
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
The GPU giant could see value in ARM's large mobile footprint and budding server CPU efforts. But a deal would also present some challenges.
Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.
Selling is broadening and speculative trading is narrowing, but it's tough to read too much into either yet.
Precious metals reverse on a strong dollar, which should trigger some rotational action.
Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.
What has changed significantly has been the value of the U.S. dollar relative to peer currencies.
FATMAANN names are leading to the downside, but small-caps and value are outperforming.
Plus, why shares of vaccine maker Moderna are taking a hit.
The delayed arrival of CPUs relying on Intel's 7nm manufacturing process node stands to make things easier for AMD in 2022 -- and perhaps longer.
Earnings reports continue to outperform, but can this support equity markets at these levels now?
Big Blue reported strong mainframe and Red Hat growth for Q2. But various other businesses had a rougher time.